Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2013
03/27/2013CN101808651B Polymer conjugate of steroid
03/27/2013CN101801322B Patch material
03/27/2013CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
03/27/2013CN101791410B Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof
03/27/2013CN101784259B Antifungal composition
03/27/2013CN101687061B Biogel
03/27/2013CN101674853B Amino acid lipids and uses thereof
03/27/2013CN101627996B Rabeprazole sodium composition and preparation method thereof
03/27/2013CN101416955B Improved cataplasm ground-mass and use thereof
03/27/2013CN101381409B N-terminally chemically modified protein compositions and methods
03/27/2013CN101346154B Water-soluble films comprising low-viscosity alginates
03/27/2013CN101304765B Conjugation of streptococcal capsular saccharides
03/27/2013CN101287498B Psma抗体-药物缀合物 Psma antibody - drug conjugates
03/27/2013CN101277715B Treatment of neurodegenerative disorders
03/27/2013CN101252914B Stable nanoparticle formulations
03/27/2013CN101198693B Variant forms of urate oxidase and use thereof
03/27/2013CN101083981B Flavonoid composition for treating oral diseases
03/26/2013US8404820 Human monoclonal antibodies against Bacillus anthracis protective antigen
03/26/2013US8404802 a targeting vector which binds to receptors associated with integrin receptors, angiogenesis; contrast agents; diagnosis of malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma
03/26/2013US8404793 Allergen suppressor, allergen-suppression processed fiber and method of producing the same
03/26/2013US8404662 Cyclodextrin-based polymers for therapeutics delivery
03/26/2013US8404455 Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
03/26/2013US8404256 Biomaterial composite composition and method of use
03/26/2013US8404222 Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
03/26/2013CA2649895C Stable hydroalcoholic oral spray formulations and methods
03/26/2013CA2580796C Modified fc molecules having peptides inserted in internal loop regions
03/26/2013CA2565295C Steroid intraocular implants having an extended sustained release for a period of greater than 2 months
03/26/2013CA2537820C Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins
03/26/2013CA2395197C Acyl pseudodipeptides which carry a functionalised auxiliary arm
03/21/2013WO2013040556A1 Compositions of jasmonate compounds and methods of use
03/21/2013WO2013040499A1 Nanoconjugates able to cross the blood-brain barrier
03/21/2013WO2013040494A1 Smarttm solid oral dosage forms
03/21/2013WO2013040417A1 Amphiphilic cationic polymers for the delivery of therapeutic agents
03/21/2013WO2013040295A2 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
03/21/2013WO2013039706A1 Drug delivery systems and applications
03/21/2013WO2013039380A1 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof
03/21/2013WO2013039167A1 Pharmaceutical composition for inhalation
03/21/2013WO2013038392A1 Peptides useful for binding to b-cell leukemic cells, conjugates, and compositions comprising same and uses thereof
03/21/2013WO2013038271A1 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
03/21/2013WO2013038137A1 Method of coating microneedle devices
03/21/2013WO2013038122A1 Method of coating microneedle devices
03/21/2013WO2013037984A1 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
03/21/2013WO2013037708A1 A fast dissolving pharmaceutical composition
03/21/2013WO2013037665A1 Vanillin compositions in liquid form
03/21/2013WO2013037479A1 Ophthtalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
03/21/2013WO2013037267A1 Variant of liraglutide and conjugate thereof
03/21/2013WO2013009826A9 Conjugating amines
03/21/2013WO2013009701A3 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
03/21/2013WO2012162555A3 Heparin nanoclusters
03/21/2013WO2012162108A9 Boron-containing compositions and methods therefor
03/21/2013WO2012161520A3 Injectable liquid composition containing docetaxel
03/21/2013WO2012149405A3 Tolerogenic synthetic nanocarriers for regulating innate immune responses
03/21/2013WO2012143497A3 Novel binder-drug conjugates (adcs) and their use
03/21/2013WO2012143496A3 Novel binder-drug conjugates (adcs) and their use
03/21/2013WO2012135592A3 Theranostic imaging agents and methods of use
03/21/2013US20130072659 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
03/21/2013US20130072579 Method of preparaing enteric hard capsule and enteric hard capsule prepared thereby
03/21/2013US20130072578 Orodispersible tablets of erythritol and isomalt
03/21/2013US20130072577 Vaporized Medicants and Methods of Use
03/21/2013US20130072576 Cationic Nanogels For Biotechnological Applications
03/21/2013US20130072575 Method and Composition for Treating Pain
03/21/2013US20130072543 Compounds and Compositions for Nucleic Acid Formulation and Delivery
03/21/2013US20130072498 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
03/21/2013US20130072476 Novel parenteral carbamazepine formulation
03/21/2013US20130072460 Methods Of Treating Retroviral Infections And Related Dosage Regimes
03/21/2013US20130072447 Enhanced oral transcompartmental delivery of therapeutic or diaganostic agents
03/21/2013US20130071476 Rapid Melt Controlled Release Taste-Masked Compositions
03/21/2013US20130071463 Implants for postoperative pain
03/21/2013US20130071452 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
03/21/2013US20130071450 Gels for transdermal delivery
03/21/2013US20130071449 Coatings of acrylamide-based copolymers
03/21/2013US20130071444 Amphiphilic Cationic Polymers and Methods of Use Thereof
03/21/2013US20130071440 Use of simple amino acids to form porous particles
03/21/2013US20130071438 Compositions and methods for the treatment of hyperplasia
03/21/2013US20130071412 Methods and compositions for stable liquid drug formulations
03/21/2013US20130071387 Pharmaceutical formulations
03/21/2013US20130071386 Immunoglobulin Formulation and Method of Preparation Thereof
03/21/2013US20130071372 Metallo-protein and tocotrienol (mp-t3) compositions with non-protein-type metal chelator and uses thereof
03/21/2013US20130071351 Combination therapy
03/21/2013US20130071349 Biodegradable polymers for lowering intraocular pressure
03/21/2013US20130071348 Nanoparticles with covalently bound surfactant for drug delivery
03/21/2013US20130071321 Delivery of agents to inflamed tissues using folate-targeted liposomes
03/21/2013US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/21/2013US20130068218 Process for producing metered dose inhaler formulations
03/21/2013CA2848979A1 Plant steroids and uses thereof
03/21/2013CA2848965A1 Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release
03/21/2013CA2848833A1 Dermal filler compositions for fine line treatment
03/21/2013CA2848785A1 A fast dissolving pharmaceutical composition
03/21/2013CA2848740A1 Amphiphilic cationic polymers for the delivery of therapeutic agents
03/21/2013CA2848219A1 Compositions of jasmonate compounds and methods of use
03/21/2013CA2848156A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
03/21/2013CA2847698A1 Nanoconjugates able to cross the blood-brain barrier
03/21/2013CA2846824A1 Pharmaceutical composition for inhalation
03/21/2013CA2845712A1 Smarttm solid oral dosage forms
03/20/2013EP2570432A1 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
03/20/2013EP2570122A1 Composition for Enhancing Transdermal Absorption of A Drug and Patch Preparation
03/20/2013EP2570120A1 Coated particle and method for producing coated particle
03/20/2013EP2570117A1 Pharmaceutical topical compositions
03/20/2013EP2569364A1 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
03/20/2013EP2569330A2 Chlorotoxin variants, conjugates, and methods for their use
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 1712